Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Guideline for Long-Term Oxygen Therapy - S2k-Guideline Published by the German Respiratory Society].
Haidl P, Jany B, Geiseler J, Andreas S, Arzt M, Dreher M, Frey M, Hauck RW, Herth F, Hämäläinen N, Jehser T, Kenn K, Lamprecht B, Magnet F, Oldenburg O, Schenk P, Schucher B, Studnicka M, Voshaar T, Windisch W, Woehrle H, Worth H; Weitere beteiligte wissenschaftliche Fachgesellschaften und Institutionen: Deutsche Atemwegsliga e. V.; Deutsche Gesellschaft für Innere Medizin e. V. (DGIM); Deutsche Gesellschaft für Kardiologie − Herz- und Kreislaufforschung e. V. (DGK); Deutsche Gesellschaft für Palliativmedizin e. V. (DGP); Deutsche Interdisziplinäre Gesellschaft für Außerklinische Beatmung (DIGAB); Bundesverband der Pneumologen, Schlaf- und Beatmungsmediziner (BdP); Schweizerische Gesellschaft für Pneumologie (SGP); Österreichische Gesellschaft für Pneumologie (ÖGP); Deutsche Sauerstoff- und BeatmungsLiga LOT e. V.. Haidl P, et al. Among authors: lamprecht b. Pneumologie. 2020 Dec;74(12):813-841. doi: 10.1055/a-1252-1492. Epub 2020 Dec 8. Pneumologie. 2020. PMID: 33291162 Free article. German.
Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.
Paz-Ares L, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, Statsenko G, Hochmair MJ, Özgüroğlu M, Ji JH, Voitko O, Poltoratskiy A, Ponce S, Verderame F, Havel L, Bondarenko I, Kazarnowicz A, Losonczy G, Conev NV, Armstrong J, Byrne N, Shire N, Jiang H, Goldman JW; CASPIAN investigators. Paz-Ares L, et al. Lancet. 2019 Nov 23;394(10212):1929-1939. doi: 10.1016/S0140-6736(19)32222-6. Epub 2019 Oct 4. Lancet. 2019. PMID: 31590988 Clinical Trial.
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.
Horn L, Mansfield AS, Szczęsna A, Havel L, Krzakowski M, Hochmair MJ, Huemer F, Losonczy G, Johnson ML, Nishio M, Reck M, Mok T, Lam S, Shames DS, Liu J, Ding B, Lopez-Chavez A, Kabbinavar F, Lin W, Sandler A, Liu SV; IMpower133 Study Group. Horn L, et al. N Engl J Med. 2018 Dec 6;379(23):2220-2229. doi: 10.1056/NEJMoa1809064. Epub 2018 Sep 25. N Engl J Med. 2018. PMID: 30280641 Clinical Trial.
[COPD today and in the year 2020].
Lamprecht B, Studnicka M. Lamprecht B, et al. Wien Klin Wochenschr. 2007;119(17-18):501-2. doi: 10.1007/s00508-007-0853-9. Wien Klin Wochenschr. 2007. PMID: 17943399 German. No abstract available.
165 results